FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Lupin Pharmaceuticals clomiPRAMINE Hydrochloride Capsules 25 mg Recall

clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boul…

Lupin Pharmaceuticals Inc. · Naples, FL

Risk level
Class II
Reported by FDA
Jul 30, 2025
Recall ID
D-0537-2025
Check your lot numberHow we source this data

Summary

Lupin Pharmaceuticals recalled clomiPRAMINE Hydrochloride Capsules 25 mg starting Jun 27, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0537-2025 on Jul 30, 2025. Reason: Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.

Product description

clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC# 68180-492-01

Lot numbers, UPCs & expiration codes

Lot # M300464, exp. date June, 2025

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0537-2025
Classification
Class II
Status
Terminated
Recall initiated
Jun 27, 2025
FDA report date
Jul 30, 2025
Quantity
2,724 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0537-2025, exactly as published.

Show all FDA fields
City
Naples
State
FL
Status
Terminated
Country
United States
Event ID
97159
Address
5801 Pelican Bay Blvd
Address (line 2)
Suite 500
Code information
Lot # M300464, exp. date June, 2025
Postal code
34108-2755
Report date
Jul 30, 2025
Product type
Drugs
Recall number
D-0537-2025
Classification
Class II
Recalling firm
Lupin Pharmaceuticals Inc.
Product quantity
2,724 bottles
Termination date
Jan 5, 2026
Reason for recall
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.
Voluntary / mandated
Voluntary: Firm initiated
Product description
clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC# 68180-492-01
Distribution pattern
Nationwide.
Recall initiation date
Jun 27, 2025
Initial firm notification
Letter
Center classification date
Jul 21, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0537-2025, published Jul 30, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls